Understanding Novel and Emerging Immunotherapies – ESMO
ESMO/LinkedIn

Understanding Novel and Emerging Immunotherapies – ESMO

European Society for Medical Oncology (ESMO) shared on LinkedIn:

Episode 2 of Innovations in Oncology: Understanding Novel and Emerging Immunotherapies is now live on OncologyPro!

Hosts Lavinia Spain, Victoria Atkinson, and Emanuela Romano are joined by Andrew Furness from The Royal Marsden Hospital, London, for a wide-ranging discussion on CAR therapies in solid tumours.

The conversation covers:

  • CAR-T, CAR-M, and CAR-NK – beyond the basics
  • The challenges of the tumour microenvironment
  • Where the pitfalls are and how the field is working to overcome them

Available now in both audio and video on OncologyPro.

Have a question on this topic? Leave a comment, and our hosts may address it in a future episode.”

ESMO

Annie Wong, Consultant Medical Oncologist at Peter MacCallum Cancer Centre and Senior Lecturer at The University of Auckland and University of Otago, Lung, added:

“Can’t wait to check this podcast out… what a powerhouse team to discuss emerging immunotherapeutics and cellular therapies